Cipla strengthens as its arm inks pact with Sri Lankan distributor

18 Jun 2014 Evaluate

Cipla is currently trading at Rs 427.95, up by 15.10 points or 3.66% from its previous closing of Rs 412.85 on the BSE.

The scrip opened at Rs 421.00 and has touched a high and low of Rs 443.20 and Rs 418.55 respectively. So far 1334204 shares were traded on the counter.

The BSE group 'A' stock of face value Rs 2 has touched a 52 week high of Rs 450.00 on 16-Sep-2013 and a 52 week low of Rs 366.70 on 24-Feb-2014.

Last one week high and low of the scrip stood at Rs 420.50 and Rs 407.15 respectively. The current market cap of the company is Rs 34324.89 crore.

The promoters holding in the company stood at 36.80% while Institutions and Non-Institutions held 34.75% and 27.35% respectively.

Cipla’s wholly owned subsidiary, Cipla (Mauritius), has signed a definitive agreement with company’s existing Sri Lankan distributor for acquisition of 60% stake in a new company which will market the company’s products in Sri Lanka. The company has paid a consideration of $14 million for this transaction. However, the acquisition will be subject to regulatory approvals.

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients. For more than 70 years, Cipla has emerged as one of the most respected pharmaceutical names in India as well as across more than 170 countries.

 

Cipla Share Price

1494.40 -10.65 (-0.71%)
29-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1717.50
Dr. Reddys Lab 1268.60
Cipla 1494.40
Zydus Lifesciences 904.00
Lupin 2079.50
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×